美国 · SEC FORM 4
RIGEL PHARMACEUTICALS INC
RIGL · Nasdaq · CIK 0001034842 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
25 同一窗口内观察到的 Form 4 交易行
2 sales · 23 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 6 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2022-06-09 · RODRIGUEZ RAUL R.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 2,855,433
- 上期报告
- 3,191,811
- 日均成交量
- 256,338
- 回补天数
- 11.1
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2022-06-09 | RODRIGUEZ RAUL R | 买入 (P) | Common Stock | 1,000,000 | USD 0.69 | USD 690,000 | SEC 申报 ↗ |
Form 4 申报证据
47 transaction lines in the latest 365-day window; 119 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | Schorno Dean L | 期权行权／转换 (M) | Common Stock | 4,600 | USD 21.72 | USD 99,929 | SEC 申报 ↗ |
| 2026-09-01 | Schorno Dean L | 代扣税 (F) | Common Stock | 928 | USD 47.50 | USD 44,080 | SEC 申报 ↗ |
| 2026-09-01 | Santos David A | 代扣税 (F) | Common Stock | 874 | USD 47.50 | USD 41,515 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | Schorno Dean L | 期权行权／转换 (M) | Common Stock | 4,600 | USD 21.72 | USD 99,929 | SEC 申报 ↗ |
| 2026-09-01 | Schorno Dean L | 代扣税 (F) | Common Stock | 928 | USD 47.50 | USD 44,080 | SEC 申报 ↗ |
| 2026-09-01 | Santos David A | 代扣税 (F) | Common Stock | 874 | USD 47.50 | USD 41,515 | SEC 申报 ↗ |
| 2026-09-01 | RODRIGUEZ RAUL R | 代扣税 (F) | Common Stock | 2,424 | USD 47.50 | USD 115,140 | SEC 申报 ↗ |
| 2026-09-01 | Furey Raymond J. | 代扣税 (F) | Common Stock | 877 | USD 47.50 | USD 41,658 | SEC 申报 ↗ |
| 2026-07-08 | HANNAH ALISON L. | 奖励／授予 (A) | Common Stock | 24,400 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-22 | Ali-Jackson Kamil | 卖出 (S) | Common Stock | 2,500 | USD 35.00 | USD 87,500 | SEC 申报 ↗ |
| 2026-06-01 | Schorno Dean L | 期权行权／转换 (M) | Common Stock | 3,381 | USD 14.83 | USD 50,139 | SEC 申报 ↗ |
| 2026-06-01 | Schorno Dean L | 代扣税 (F) | Common Stock | 928 | USD 29.86 | USD 27,710 | SEC 申报 ↗ |
| 2026-06-01 | Santos David A | 代扣税 (F) | Common Stock | 874 | USD 29.86 | USD 26,098 | SEC 申报 ↗ |
| 2026-06-01 | Rojkjaer Lisa | 代扣税 (F) | Common Stock | 850 | USD 29.86 | USD 25,381 | SEC 申报 ↗ |
| 2026-06-01 | RODRIGUEZ RAUL R | 代扣税 (F) | Common Stock | 2,424 | USD 29.86 | USD 72,381 | SEC 申报 ↗ |
| 2026-06-01 | Furey Raymond J. | 代扣税 (F) | Common Stock | 877 | USD 29.86 | USD 26,187 | SEC 申报 ↗ |
| 2026-05-26 | Ali-Jackson Kamil | 卖出 (S) | Common Stock | 2,500 | USD 29.17 | USD 72,925 | SEC 申报 ↗ |
| 2026-05-15 | Wasman Jane | 奖励／授予 (A) | Common Stock | 5,750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-15 | MOOS WALTER H | 奖励／授予 (A) | Common Stock | 5,750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-15 | MILLER MICHAEL PATRICK | 奖励／授予 (A) | Common Stock | 5,750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-15 | LAPOINTE ANTHONY GREGG | 奖励／授予 (A) | Common Stock | 5,750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-15 | HANNAH ALISON L. | 奖励／授予 (A) | Common Stock | 5,750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-15 | Frohlich Mark W | 奖励／授予 (A) | Common Stock | 5,750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-15 | Ali-Jackson Kamil | 奖励／授予 (A) | Common Stock | 5,750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-20 | MOOS WALTER H | 卖出 (S) | Common Stock | 4,000 | USD 36.36 | USD 145,440 | SEC 申报 ↗ |
| 2026-02-20 | MOOS WALTER H | 期权行权／转换 (M) | Common Stock | 4,000 | USD 24.00 | USD 96,000 | SEC 申报 ↗ |
| 2026-02-17 | Schorno Dean L | 奖励／授予 (A) | Common Stock | 20,636 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-17 | Santos David A | 奖励／授予 (A) | Common Stock | 19,430 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-17 | Rojkjaer Lisa | 奖励／授予 (A) | Common Stock | 18,894 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-17 | RODRIGUEZ RAUL R | 奖励／授予 (A) | Common Stock | 53,915 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-17 | Furey Raymond J. | 奖励／授予 (A) | Common Stock | 19,497 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-10 | Schorno Dean L | 代扣税 (F) | Common Stock | 3,546 | USD 34.62 | USD 122,763 | SEC 申报 ↗ |
| 2026-02-10 | Santos David A | 代扣税 (F) | Common Stock | 3,546 | USD 34.62 | USD 122,763 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | RIGL |
| CIK | 0001034842 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 119 transaction lines from 2021-05-19 to 2026-09-02 1 P purchase lines · 21 S sale lines · 97 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.